Burkitt Lymphoma

Explore clinical trials studying Burkitt Lymphoma. Study availability and eligibility vary by location and protocol.

695 public trials 115 recruiting studies

Refine in advanced search Browse all conditions

Burkitt Lymphoma trial results

Active, Not Recruiting

NCT04464200

Conditions: Blood Protein Disorders, Burkitt Lymphoma, Burkitt's Lymphoma, +41 more
Locations: Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States

Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States

Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States

Memorial Sloan Kettering Cancer Commack - Suffolk (Limited Protocol Activities) Commack, New York, United States

Active, Not Recruiting

NCT06220097

Conditions: B-cell Acute Lymphoblastic Leukemia, B-cell Lymphoma Refractory, Burkitt Lymphoma, +16 more
Locations: Union Hospital, Huazhong University of Science and Technology Wuhan, Hubei, China

Active, Not Recruiting

NCT05263583

Conditions: Burkitt Lymphoma, C-MYC/BCL2 Double-Hit High-Grade B-Cell Lymphoma, C-MYC/BCL6 Double-Hit High-Grade B-Cell Lymphoma, +24 more
Locations: Beijing Cancer Hospital Beijing, China

Sun Yat-sen University Cancer Center Guangzhou, China

Henan Cancer Hospital Henan, China

Shanghai East Hospital Pudong, China

Active, Not Recruiting

NCT03962465

Conditions: B-cell Acute Lymphoblastic Leukemia, Burkitt Lymphoma, DNA Virus Infections, +15 more
Locations: Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States

University of Virginia Charlottesville, Virginia, United States

VCU Massey Cancer Center Richmond, Virginia, United States

University of Wisconsin Madison, Wisconsin, United States

Active, Not Recruiting

NCT04214886

Conditions: B-Cell Acute Lymphoblastic Leukemia, Adult, B-cell Lymphoma Recurrent, B-cell Lymphoma Refractory, +19 more
Locations: Loyola University Maywood, Illinois, United States